Overview

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

Status:
RECRUITING

Trial end date:
2025-10-06

Target enrollment:

Participant gender:

Summary

This study is being conducted to assess the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participants.

Phase:

PHASE1

Details

Lead Sponsor:

Incyte Corporation

Treatments:

Esomeprazole
Famotidine